City
Epaper

Researchers develop fast, accurate, low-cost Covid-19 test

By IANS | Updated: August 29, 2020 18:04 IST

Beijing, Aug 29 Chinese researchers have developed a new low-cost diagnostic test for Covid-19 which quickly delivers accurate ...

Open in App

Beijing, Aug 29 Chinese researchers have developed a new low-cost diagnostic test for Covid-19 which quickly delivers accurate results without the need for sophisticated equipment.

"In this study, we developed an isothermal, CRISPR-based diagnostic for Covid-19 with near single-copy sensitivity," the study authors from Xuzhou Medical University in China, wrote in a paper published in the journal PLOS Pathogens.

"We demonstrated a CRISPR-based assay for Covid-19 that offered shorter turn-around time and great diagnostic value, even in under-resourced settings without the need for thermal cyclers," they added.

The surging demand for rapid screening and identification of Covid-19 poses great diagnostic challenges.

Metagenomic next-generation sequencing (mNGS) and reverse-transcription PCR (RT-PCR) have been the most commonly used molecular methods for diagnosing Covid-19, but each has its own limitations.

For example, sequencing is costly and has a turnaround time of nearly one day, while RT-PCR requires specialized equipment and is difficult to deploy at a large scale.

According to the researchers, a lack of rapid and accurate molecular diagnostic tools has hampered efficient public health responses to the viral threat.

In the new study, the researchers developed an alternative Covid-19 test by leveraging CRISPR-based technology, which has been widely used in recent years for gene editing.

The assay, named CRISPR-COVID, enables high-throughput detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the virus that causes Covid-19.

CRISPR-COVID delivers comparable sensitivity and specificity as mNGS within as short as 40 minutes, the researchers said.

When produced at a large scale, the material cost of a CRISPR-COVID test could be less than 70 cents, suggesting that CRISPR-COVID is a competitive alternative not only technologically but also financially, the team noted.

( With inputs from IANS )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Xuzhou Medical UniversityPlos pathogenschinabeijing
Open in App

Related Stories

InternationalBeijing Rains: 44 Dead and 9 Missing Due to Torrential Rainfall in China

InternationalTsunami Alert Issued in Parts of China After 8.8-Magnitude Earthquake Strikes Off Russian Coast

National"Never Said Trump Was Lying, Didn't Mention China Even Once": Rahul Gandhi on PM Modi's Operation Sindoor Speech (Watch Video)

OpinionsAfter ‘Cloud Bomb’, ‘Water Bomb’ Now?

International‘This Might Hit You Hard’: NATO Chief Mark Rutte's Warning to India, China, and Brazil Over Russia Ties Amid Ukraine War

Health Realted Stories

HealthSouth Korea: Heat-related death toll rises to 19 amid extreme heat wave

HealthPunjab to open 200 new Aam Aadmi Clinics, taking total number to 1,081: CM Mann

HealthIs Formula Feeding Pushing Mothers Away From Breastfeeding? Here Are the Benefits Every Newborn’s Mother Should Know

HealthCentre cuts prices of 35 essential medicines

HealthSpecial edition of 'Fit India-Sundays on Cycle' held at JLN Stadium today